HR 7369
115th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Health care quality
Health facilities and institutions
Licensing and registrations
Medicare
Prescription drugs
DEA Notification Act of 2018
Introduced: December 20, 2018
Introduced by:
Bilirakis, Gus M.
Republican
· Florida
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 20, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 20, 2018
Introduced in House
Plain-English summary
DEA Notification Act of 2018
This bill requires the Centers for Medicare & Medicaid Services to notify the Drug Enforcement Administration (DEA) of providers or suppliers that are prohibited from participating in Medicare due to improper prescriptions of controlled substances, and to recommend that the DEA consider revoking certain controlled substance registrations or waivers held by such providers or suppliers.
What's happening now
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees of jurisdiction
3
Cosponsors
1